247 related articles for article (PubMed ID: 26671069)
1. Pharmacological Blockade of Cannabinoid CB1 Receptors in Diet-Induced Obesity Regulates Mitochondrial Dihydrolipoamide Dehydrogenase in Muscle.
Arrabal S; Lucena MA; Canduela MJ; Ramos-Uriarte A; Rivera P; Serrano A; Pavón FJ; Decara J; Vargas A; Baixeras E; Martín-Rufián M; Márquez J; Fernández-Llébrez P; De Roos B; Grandes P; Rodríguez de Fonseca F; Suárez J
PLoS One; 2015; 10(12):e0145244. PubMed ID: 26671069
[TBL] [Abstract][Full Text] [Related]
2. Effects of cannabinoid receptors on skeletal muscle oxidative pathways.
Cavuoto P; McAinch AJ; Hatzinikolas G; Cameron-Smith D; Wittert GA
Mol Cell Endocrinol; 2007 Mar; 267(1-2):63-9. PubMed ID: 17270342
[TBL] [Abstract][Full Text] [Related]
3. Diet-dependent modulation of hippocampal expression of endocannabinoid signaling-related proteins in cannabinoid antagonist-treated obese rats.
Rivera P; Luque-Rojas MJ; Pastor A; Blanco E; Pavón FJ; Serrano A; Crespillo A; Vida M; Grondona JM; Cifuentes M; Bermúdez-Silva FJ; de la Torre R; de Fonseca FR; Suárez J
Eur J Neurosci; 2013 Jan; 37(1):105-17. PubMed ID: 23033907
[TBL] [Abstract][Full Text] [Related]
4. Expression of the cannabinoid system in muscle: effects of a high-fat diet and CB1 receptor blockade.
Crespillo A; Suárez J; Bermúdez-Silva FJ; Rivera P; Vida M; Alonso M; Palomino A; Lucena MA; Serrano A; Pérez-Martín M; Macias M; Fernández-Llébrez P; Rodríguez de Fonseca F
Biochem J; 2011 Jan; 433(1):175-85. PubMed ID: 20955176
[TBL] [Abstract][Full Text] [Related]
5. CB1 blockade potentiates down-regulation of lipogenic gene expression in perirenal adipose tissue in high carbohydrate diet-induced obesity.
Vida M; Rivera P; Gavito AL; Suárez J; Pavón FJ; Arrabal S; Romero-Cuevas M; Bautista D; Martínez A; de Fonseca FR; Serrano A; Baixeras E
PLoS One; 2014; 9(2):e90016. PubMed ID: 24587189
[TBL] [Abstract][Full Text] [Related]
6. The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance.
Jbilo O; Ravinet-Trillou C; Arnone M; Buisson I; Bribes E; Péleraux A; Pénarier G; Soubrié P; Le Fur G; Galiègue S; Casellas P
FASEB J; 2005 Sep; 19(11):1567-9. PubMed ID: 16009704
[TBL] [Abstract][Full Text] [Related]
7. Peripheral, but not central, CB1 antagonism provides food intake-independent metabolic benefits in diet-induced obese rats.
Nogueiras R; Veyrat-Durebex C; Suchanek PM; Klein M; Tschöp J; Caldwell C; Woods SC; Wittmann G; Watanabe M; Liposits Z; Fekete C; Reizes O; Rohner-Jeanrenaud F; Tschöp MH
Diabetes; 2008 Nov; 57(11):2977-91. PubMed ID: 18716045
[TBL] [Abstract][Full Text] [Related]
8. Responses to the cannabinoid receptor-1 antagonist, AM251, are more robust with age and with high-fat feeding.
Judge MK; Zhang Y; Scarpace PJ
J Endocrinol; 2009 Nov; 203(2):281-90. PubMed ID: 19679649
[TBL] [Abstract][Full Text] [Related]
9. CB
O'Keefe L; Vu T; Simcocks AC; Jenkin KA; Mathai ML; Hryciw DH; Hutchinson DS; McAinch AJ
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232744
[TBL] [Abstract][Full Text] [Related]
10. Selection of a palatable dietary option is not preferentially reduced by cannabinoid CB1 receptor antagonist AM251 in female C57Bl/6J mice.
Mathes CM; Ferrara M; Rowland NE
Pharmacol Biochem Behav; 2009 Nov; 94(1):119-23. PubMed ID: 19660493
[TBL] [Abstract][Full Text] [Related]
11. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity.
Ravinet Trillou C; Delgorge C; Menet C; Arnone M; Soubrié P
Int J Obes Relat Metab Disord; 2004 Apr; 28(4):640-8. PubMed ID: 14770190
[TBL] [Abstract][Full Text] [Related]
12. Comparison of independent and combined chronic metabolic effects of GIP and CB1 receptor blockade in high-fat fed mice.
Irwin N; Hunter K; Flatt PR
Peptides; 2008 Jun; 29(6):1036-41. PubMed ID: 18291559
[TBL] [Abstract][Full Text] [Related]
13. The central cannabinoid CB1 receptor is required for diet-induced obesity and rimonabant's antiobesity effects in mice.
Pang Z; Wu NN; Zhao W; Chain DC; Schaffer E; Zhang X; Yamdagni P; Palejwala VA; Fan C; Favara SG; Dressler HM; Economides KD; Weinstock D; Cavallo JS; Naimi S; Galzin AM; Guillot E; Pruniaux MP; Tocci MJ; Polites HG
Obesity (Silver Spring); 2011 Oct; 19(10):1923-34. PubMed ID: 21799481
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid receptor 1 and acute resistance exercise--In vivo and in vitro studies in human skeletal muscle.
Pekkala S; Wiklund P; Hulmi JJ; Pöllänen E; Marjomäki V; Munukka E; Pierre P; Mouly V; Mero A; Alén M; Cheng S
Peptides; 2015 May; 67():55-63. PubMed ID: 25796352
[TBL] [Abstract][Full Text] [Related]
15. Obesity-dependent cannabinoid modulation of proliferation in adult neurogenic regions.
Rivera P; Romero-Zerbo Y; Pavón FJ; Serrano A; López-Ávalos MD; Cifuentes M; Grondona JM; Bermúdez-Silva FJ; Fernández-Llebrez P; de Fonseca FR; Suárez J; Pérez-Martín M
Eur J Neurosci; 2011 May; 33(9):1577-86. PubMed ID: 21395869
[TBL] [Abstract][Full Text] [Related]
16. Additive actions of the cannabinoid and neuropeptide Y systems on adiposity and lipid oxidation.
Zhang L; Lee NJ; Nguyen AD; Enriquez RF; Riepler SJ; Stehrer B; Yulyaningsih E; Lin S; Shi YC; Baldock PA; Herzog H; Sainsbury A
Diabetes Obes Metab; 2010 Jul; 12(7):591-603. PubMed ID: 20590734
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effects of cannabinoid inverse agonist AM251 and opioid antagonist nalmefene on food intake in mice.
Chen RZ; Huang RR; Shen CP; MacNeil DJ; Fong TM
Brain Res; 2004 Mar; 999(2):227-30. PubMed ID: 14759503
[TBL] [Abstract][Full Text] [Related]
18. Antidiabetic effects of sub-chronic administration of the cannabinoid receptor (CB1) antagonist, AM251, in obese diabetic (ob/ob) mice.
Irwin N; Hunter K; Frizzell N; Flatt PR
Eur J Pharmacol; 2008 Feb; 581(1-2):226-33. PubMed ID: 18191122
[TBL] [Abstract][Full Text] [Related]
19. NESS038C6, a novel selective CB1 antagonist agent with anti-obesity activity and improved molecular profile.
Mastinu A; Pira M; Pani L; Pinna GA; Lazzari P
Behav Brain Res; 2012 Oct; 234(2):192-204. PubMed ID: 22771813
[TBL] [Abstract][Full Text] [Related]
20. Food intake-independent effects of CB1 antagonism on glucose and lipid metabolism.
Cota D; Sandoval DA; Olivieri M; Prodi E; D'Alessio DA; Woods SC; Seeley RJ; Obici S
Obesity (Silver Spring); 2009 Aug; 17(8):1641-5. PubMed ID: 19325539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
